Expression of MRB and cMOAT in childhood neuroblastomas and malignant liver tumors and its relevance to clinical behavior

Japanese Journal of Cancer Research

Volumn 89, Issue 12, 1998, Pages 1276-1283

  Matsunaga, Tadashi ^a   Shirasawa, Hiroshi ^a   Hishiki, Tomoro ^a   Enomoto, Hideki ^a   Kouchi, Katsunori ^a   Ohtsuka, Yasuhiro ^a   Iwai, Jun ^a   Yoshida, Hideo ^a   Tanabe, Masahiro ^a   Kobayashi, Susumu ^a   Asano, Takehide ^a   Etoh, Takao ^b   Nishi, Yoshisuke ^c   Ohnuma, Naomi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA CHILDREN'S HOSPITAL   (Japan)

^c JAPAN TOBACCO INC   (Japan)

Author keywords

Childhood malignant liver tumor; cMOAT; MRP; N myc; Neuroblastoma

Indexed keywords

CARRIER PROTEIN; CISPLATIN; DOXORUBICIN; MULTIDRUG RESISTANCE PROTEIN; RNA; ABC TRANSPORTER; ANION TRANSPORT PROTEIN; ANTINEOPLASTIC AGENT; HYBRID PROTEIN; MYC PROTEIN; NERVE PROTEIN; TUMOR PROTEIN;

ARTICLE; CELL LINE; CHILDHOOD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; LIVER CANCER; LIVER CELL CARCINOMA; MULTIDRUG RESISTANCE; NEUROBLASTOMA; ONCOGENE C MYB; OUTCOMES RESEARCH; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; CHILD; DISEASE COURSE; DRUG RESISTANCE; FOLLOW UP; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; METABOLISM; MORTALITY; ONCOGENE MYC; PHYSIOLOGY; SURVIVAL; TREATMENT OUTCOME;

ANION TRANSPORT PROTEINS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ATP-BINDING CASSETTE TRANSPORTERS; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; CHILD; DISEASE PROGRESSION; DRUG RESISTANCE, NEOPLASM; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; HUMANS; LIVER NEOPLASMS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; NEUROBLASTOMA; ORGAN SPECIFICITY; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-MYC; RECOMBINANT FUSION PROTEINS; SURVIVAL ANALYSIS; TRANSFECTION; TREATMENT OUTCOME;

EID: 0032216703     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1998.tb00524.x     Document Type: Article

References (30)

1. Germann, U. A. P-glycoprotein : a mediator of multidrug resistance in tumour cells. Eur. J. Cancer, 32A, 927-944 (1996).
2. Bourhis, J., Benard, J., Hartmann, O., Boccon-Gibod, L., Lemerle, J. and Riou, G. Correlation of MDR1 gene expression with chemotherapy in neuroblastoma. J. Natl. Cancer Inst., 81, 1401-1405 (1989).
3. Nakagawara, A., Kadomatsu, K., Sato, S., Kohno, K., Takano, H., Akazawa, K., Nose, Y. and Kuwano, M. Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas. Cancer Res., 50, 3043-3047 (1990).
4. Chan, H. S. L., Haddad, G., Thorner, P. S., DeBoer, G., Lin, Y. P., Ondrusek, N., Yeger, H. and Ling, V. P-Glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N. Engl. J. Med., 325, 1608-1614 (1991).
5. Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V. and Deeley, R. G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science, 258, 1650-1654 (1992).
6. Loe, D. W., Deeley, R. G. and Cole, S. P. C. Biology of the multidrug resistance-associated protein, MRP. Eur. J. Cancer, 32A, 945-957 (1996).
7. Nooter, K., Westerman, A. M., Flens, M. J., Zaman, J. R., Scheper, R. J., van Wingerden, K. E., Burger, H., Oostrum, R., Boersma, T., Sonneveld, P., Gratama, J. W., Kok, T., Eggermont, A. M. M., Bosman, F. T. and Stoter, G. Expression of the multidrug resistance-associated protein (MRP) gene in human cancers. Clin. Cancer Res., 1, 1301-1310 (1995).
8. Grant, C. E., Valdimarsson, G., Hipfner, D. R., Almquist, K. C., Cole, S. P. C. and Deeley, R. G. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res., 54, 357-361 (1994).
9. Bordow, S. B., Haber, M., Madafiglio, J., Cheung, B., Marshall, G. M. and Morris, M. D. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma. Cancer Res., 54, 5036-5049 (1994).
10. Norris, M. D., Bordow, S. B., Marshall, G. M., Haber, P. S., Cohn, S. L. and Haber, M. Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. N. Engt. J. Med., 334, 231-238 (1996).
11. Taniguchi, K., Wada, M., Kohno, K., Nakamura, T., Kawabe, T., Kawakami, M., Kagotani, K., Okumura, K., Akiyama, S. and Kuwano, M. A human canalicular multi-specific organic anion transporter (cMOAT) gene is over-expressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res., 56, 4124-4129 (1996).
12. Koike, K., Kawabc, T., Tanaka, T., Toh, S., Uchiumi, T., Wada, M., Akiyama, S., Ono, M. and Kuwano, M. A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells. Cancer Res., 57, 5475-5479 (1997).
13. Narasaki, R, Oka, M., Nakano, R., Ikeda, K., Fukuda, M., Nakamura, T., Soda, H., Nakagawa, M., Kuwano, M. and Kohno, S. Human canalicular multispecific organic anion transporter (cMOAT) is expressed in human lung, gastric, and colorectal cancer cells. Biochem. Biophys. Res. Commun., 240, 606-611 (1997).
14. Noonan, K. E., Beck, C., Holmayer, T. A., Chin, J. E., Wunder, J. S., Andrulis, I. L., Gazdar, A. F., Willman, C. L., Griffith, B., Von Hoff, D. D. and Roninson, I. B. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc. Natl. Acad. Sci. USA, 87, 7160-7164 (1990).
15. Matsunaga, T., Shirasawa, H., Enomoto, H., Yoshida, H., Iwai, J., Tanabe, M., Kawamura, K., Etoh, T. and Ohnuma, N. Neuronal src and trk A protooncogenes expression in neuroblastomas and patient prognosis. Int. J. Cancer, 79, 226-231 (1998).
16. Brodeur, G. M., Seeger, R. C., Schwab, M., Varmus, H. and Bishop, J. M. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science, 224, 1121-1124 (1984).
17. Sugimoto, T., Sawada, T., Matsumura, T., Kemshead, J. T., Ishii, T., Horii, Y., Morioka, H., Morita, M. and Reynolds, C. P. Identical expression of cell surface membrane antigens on two parent and eighteen cloned cell lines derived from two different neuroblastoma metastases of the same patient. Cancer Res., 46, 4765-4769 (1986).
18. Matsunaga, T., Shirasawa, H., Tanabe, M, Ohnuma, N., Takahashi, H. and Simizu, B. Expression of alternatively spliced src messenger RNAs related to neuronal differentiation in human neuroblastomas. Cancer Res., 53, 3179-3185 (1993).
19. Akiyama, K. and Nishi, Y. Cloning and physical mapping of DNA sequences encompassing a region in N-myc amplicons of a human neuroblastoma cell line. Nucleic Acids Res., 19, 6887-6894 (1991).
20. Stanton, L. W., Schwab, M. and Bishop, J. M. Nucleotide sequence of the human N-myc gene. Proc. Natl. Acad. Sci. USA, 83, 1772-1776 (1986).
21. Zaman, G. J. R., Versantvoort, C. H. M., Smit, J. J. M., Eijdems, E. W. H. M., de Haas, M., Smith, A. J., Broxterman, H. J., Mulder, N. H., de Vries, E. G. E., Baas, F. and Borst, P. Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res., 53, 1747-1750 (1993).
22. Kool, M., de Haas, M., Scheffer, G. L., Scheper, R. J., van Eijk, M. J. T., Juijn, J. A., Baas, F. and Borst, P. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res., 57, 3537-3547 (1997).
23. Zimmerman, K. A., Yancopoulos, G. D., Collum, R. G., Smith, R. K., Kohl, N. E., Denis, K. A., Nau, M. M., Witte, W. N., Toran-Allerand, D., Gee, C. E., Minna, J. D. and Alt, F. W. Differential expression of myc family genes during murine development. Nature, 319, 780-783 (1986).
24. Nisen, P. D., Waber, P. G., Rich, M. A., Pierce, S., Garvin, J. R., Jr., Gilbert, F. and Lanzkowsky, P. N-myc oncogene RNA expression in neuroblastoma. J. Natl. Cancer Inst., 80, 1633-1637 (1988).
25. Slavc, I., Ellenbogen, R., Jung, W.-H., Vawter, G. F., Kretschmar, C., Grier, H. and Korf, B. R. myc gene amplification and expression in primary human neuroblastoma. Cancer Res., 50, 1459-1463 (1990).
26. Nakagawara, A., Arima-Nakagawara, M., Scavarda, N. J., Azar, C. G., Cantor, A. B. and Brodeur, G. M. Association between high levels of expression of the trk gene and favorable outcome in human neuroblastoma. N. Engl. J. Med., 328, 847-854 (1993).
27. Tanaka, T., Hiyama, E., Sugimoto, T., Sawada, T., Tanabe, M. and Ida, N. trk A gene expression in neuroblastoma. Cancer, 76, 1086-1095 (1995).
28. Matsunaga, T., Shirasawa, H., Tanabe, M., Ohnuma, N., Kawamura, K., Etoh, T., Takahashi, H. and Simizu, B. Expression of neuronal src mRNA as a favorable marker and inverse correlation to N-myc gene amplification in human neuroblastomas. Int. J. Cancer, 58, 793-798 (1994).
29. Matsunaga, T., Takahashi, H., Ohnuma, N., Tanabe, M., Yoshida, H., Iwai, J., Shirasawa, H. and Simizu, B. Expression of N-myc and c-src protooncogenes correlating to the undifferentiated phenotype and prognosis of primary neuroblastomas. Cancer Res., 51, 3148-3152 (1991).
30. Quinn, J. J., Altman, A. J., Robinson, H. T., Cooke, R. W., Might, D. W. and Foster, J. H. Adriamycin and cisplatin for hepatoblastoma. Cancer, 56, 1926-1929 (1985).